146 related articles for article (PubMed ID: 34825161)
1. miR122-controlled all-in-one nanoplatform for
Meng L; Wang Q; Wang L; Zhao Z; Xin GZ; Zheng Z; Zhou P; Li P; Jiang Y; Li HJ
Mater Today Bio; 2021 Sep; 12():100157. PubMed ID: 34825161
[TBL] [Abstract][Full Text] [Related]
2. A sensitive upconverting nanoprobe based on signal amplification technology for real-time in situ monitoring of drug-induced liver injury.
Meng L; Zheng X; Zheng Z; Zhao Z; Wang L; Zhou P; Xin GZ; Li P; Li HJ
Nanoscale; 2020 Jul; 12(28):15325-15335. PubMed ID: 32648877
[TBL] [Abstract][Full Text] [Related]
3. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
4. Ultrasensitive upconverting nanoprobes for in situ imaging of drug-induced liver injury using miR-122 as the biomarker.
Wang QL; Meng LC; Zhao Z; Du JF; Li P; Jiang Y; Li HJ
Talanta; 2024 Jul; 274():126108. PubMed ID: 38640602
[TBL] [Abstract][Full Text] [Related]
5. Theranostic Nanoplatform with Hydrogen Sulfide Activatable NIR Responsiveness for Imaging-Guided On-Demand Drug Release.
Shi B; Ren N; Gu L; Xu G; Wang R; Zhu T; Zhu Y; Fan C; Zhao C; Tian H
Angew Chem Int Ed Engl; 2019 Nov; 58(47):16826-16830. PubMed ID: 31532051
[TBL] [Abstract][Full Text] [Related]
6. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional nanotheranostic gold nanocages for photoacoustic imaging guided radio/photodynamic/photothermal synergistic therapy.
Xu X; Chong Y; Liu X; Fu H; Yu C; Huang J; Zhang Z
Acta Biomater; 2019 Jan; 84():328-338. PubMed ID: 30500447
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment-Responsive Theranostic Nanoplatform for in Situ Self-Boosting Combined Phototherapy through Intracellular Reassembly.
Liu Y; Jing J; Jia F; Su S; Tian Y; Gao N; Yang C; Zhang R; Wang W; Zhang X
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6966-6977. PubMed ID: 31965785
[TBL] [Abstract][Full Text] [Related]
9. Supramolecular Valves Functionalized Rattle-Structured UCNPs@hm-SiO
Zhou S; Ding C; Wang Y; Jiang W; Fu J
ACS Biomater Sci Eng; 2019 Nov; 5(11):6022-6035. PubMed ID: 33405724
[TBL] [Abstract][Full Text] [Related]
10. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.
Zhang X; Xi Z; Machuki JO; Luo J; Yang D; Li J; Cai W; Yang Y; Zhang L; Tian J; Guo K; Yu Y; Gao F
ACS Nano; 2019 May; 13(5):5306-5325. PubMed ID: 31018094
[TBL] [Abstract][Full Text] [Related]
11. An effective NIR laser/tumor-microenvironment co-responsive cancer theranostic nanoplatform with multi-modal imaging and therapies.
Cheng H; Wang X; Liu X; Wang X; Wen H; Cheng Y; Xie A; Shen Y; Tang R; Zhu M
Nanoscale; 2021 Jun; 13(24):10816-10828. PubMed ID: 34113940
[TBL] [Abstract][Full Text] [Related]
12. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
Li X; Schumann C; Albarqi HA; Lee CJ; Alani AWG; Bracha S; Milovancev M; Taratula O; Taratula O
Theranostics; 2018; 8(3):767-784. PubMed ID: 29344305
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
Lin W; Zhang X; Qian L; Yao N; Pan Y; Zhang L
Biomacromolecules; 2017 Dec; 18(12):3869-3880. PubMed ID: 29032674
[TBL] [Abstract][Full Text] [Related]
14. DNA-assisted upconversion nanoplatform for imaging-guided synergistic therapy and laser-switchable drug detoxification.
Li L; Hao P; Wei P; Fu L; Ai X; Zhang J; Zhou J
Biomaterials; 2017 Aug; 136():43-55. PubMed ID: 28511143
[TBL] [Abstract][Full Text] [Related]
15. Artificial nano-red blood cells nanoplatform with lysosomal escape capability for ultrasound imaging-guided on-demand pain management.
Qiao B; Song X; Zhang N; Xu M; Zhuang B; Guo H; Wu W; Yang Z; Xie X; Luan Y; Zhang C
Acta Biomater; 2023 Mar; 158():798-810. PubMed ID: 36638944
[TBL] [Abstract][Full Text] [Related]
16. A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics.
Wang Q; Sui G; Wu X; Teng D; Zhu L; Guan S; Ran H; Wang Z; Wang H
Acta Biomater; 2020 Jan; 102():367-383. PubMed ID: 31778831
[TBL] [Abstract][Full Text] [Related]
17. Self-Assembled Supramolecular Bilayer Nanoparticles Composed of Near-Infrared Dye as a Theranostic Nanoplatform To Encapsulate Hydrophilic Drugs Effectively.
Jeong C; Noh I; Rejinold NS; Kim J; Jon S; Kim YC
ACS Biomater Sci Eng; 2020 Jan; 6(1):474-484. PubMed ID: 33463245
[TBL] [Abstract][Full Text] [Related]
18. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
19. A uPAR targeted nanoplatform with an NIR laser-responsive drug release property for tri-modal imaging and synergistic photothermal-chemotherapy of triple-negative breast cancer.
Yu S; Huang G; Yuan R; Chen T
Biomater Sci; 2020 Jan; 8(2):720-738. PubMed ID: 31777866
[TBL] [Abstract][Full Text] [Related]
20. Designing of UCNPs@Bi@SiO
Zhao S; Tian R; Shao B; Feng Y; Yuan S; Dong L; Zhang L; Liu K; Wang Z; You H
ACS Appl Mater Interfaces; 2019 Jan; 11(1):394-402. PubMed ID: 30543291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
